Pediatrix Medical Group, Inc.

NYSE:MD

Medical - Care Facilities

Healthcare
$30.84 -2.04%

-$0.48 today

Market cap
$2.41B
Beta
0.70
P/E (TTM)
11.0
EPS (TTM)
$2.10
52W Low $11.84High $24.99

Volume 0.64M

Average 0.82M

MD Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Pediatrix Medical Group, Inc.NYSE: MD

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation grows, but more slowly than its trailing trend

Q3 FY2026 stock-based compensation of $6.2M rose 20.3% year over year, behind the +37.8% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 22.1% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.

Context

  • Stock-based compensation amounted to 0.9% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +20.3% toward the trailing-twelve-month pace of +37.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$6.2M+22.1% QoQ
Last fiscal yearDec 2025
$18.05M+52.0% YoY
LTMSep 2026
$21.28M+37.8% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.3%——
1 year+52.0%——
3-year CAGR+3.8%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
18.05M USD
Year-over-year change
+52.0%
4-year CAGR
-1.2%

Stock-Based Compensation vs competitors

How MD compares with its peers on the latest reported figures

  • MD's LTM Sep 2026 stock-based compensation of $21.28M is the 7th largest of the 11 companies compared; the peer median is $25.63M.
  • Its year-over-year change of +37.8% is the 3rd highest of 11, against a peer median of +5.0%.
  • Stock-based compensation amounts to 1.1% of revenue for MD, versus a peer median of 0.7%.
MD Competitors Peer median
Stock-Based Compensation for MD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LFSTLifeStance Health Group, Inc.LTM Jun 2026$69.95M -1.1%-26.4%4.4%
ASTHAstrana Health, Inc.LTM Mar 2026$40.69M +11.2%+33.8%1.2%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$34.64M +37.2%+2.3%1.0%
ARDTArdent Health Partners, LLCLTM Mar 2026$29.29M +216.2%+300.6%0.5%
OGNOrganon & Co.LTM Sep 2026$28.04M -70.8%+0.9%0.5%
ADUSAddus HomeCare CorporationLTM Jun 2026$23.22M +74.9%+15.6%1.6%
MDPediatrix Medical Group, Inc.LTM Sep 2026$21.28M +37.8%+3.8%1.1%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$16.97M -165.0%—0.6%
SEMSelect Medical Holdings CorporationLTM Mar 2026$12.18M -86.9%-23.8%0.2%
GRDNGuardian Pharmacy Services, Inc.LTM Jun 2026$10.23M -92.4%—0.7%
NHCNational HealthCare CorporationLTM Sep 2026$6.19M +34.5%+19.0%0.4%
Peer median (excluding MD) $25.63M+5.0%+9.0%0.7%

Competitors are the stored peer set for MD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income108.01M62.57M(60.41M)(99.07M)165.39M
Depreciation & Amortization32.15M35.64M36.17M32.23M21.83M
Deferred Income Tax(31.24M)(22.77M)3.24M(2.13M)52.19M
Stock-Based Compensation18.97M16.13M12.32M11.87M18.05M
Change in Working Capital(23.36M)31.83M(11.63M)88.24M41.83M
Accounts Receivables(72.73M)(5.54M)26.28M10.29M30.56M
Inventory00000
Accounts Payables21.33M420K(11.92M)51.14M28.33M
Other Working Capital28.05M36.95M(25.98M)26.81M(17.06M)
Other Non-Cash Items(27.8M)43.55M157.63M175.44M(28.18M)
Operating Cash Flow76.74M166.94M137.33M206.57M271.09M
Capital Expenditures(32.25M)(29.71M)(33.33M)(22.02M)(18.46M)
Acquisitions (Net)(29.93M)(28.17M)(6.67M)(8.17M)6.8M
Purchases of Investments(35.05M)(17.35M)(31.89M)(64.55M)(29.85M)
Sales of Investments16.5M16.89M22.91M52.49M26.67M
Other Investing Activities27.66M1.38M807K6.84M(3.47M)
Investing Cash Flow(53.07M)(56.95M)(48.18M)(35.41M)(18.3M)
Debt Repayment(762.66M)(405.17M)(19.12M)(15.39M)(20.75M)
Common Stock Issued6.85M5.4M4.91M3.64M3.18M
Common Stock Repurchased(4.72M)(88.51M)(919K)(1.7M)(86.68M)
Dividends Paid00000
Other Financing Activities407K732K(10.59M)(1.03M)(3.25M)
Financing Cash Flow(760.12M)(487.55M)(25.72M)(14.49M)(107.49M)
Effect of Forex Changes00000
Net Change in Cash(736.45M)(377.57M)63.43M156.68M145.3M
Free Cash Flow44.49M137.23M104M184.55M252.63M

Pediatrix Medical Group, Inc.

NYSE:MD

Intrinsic Alpha fair value

Locked

Current Price

$30.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.